Attached files
file | filename |
---|---|
EX-21 - EXHIBIT 21 - NOVELION THERAPEUTICS INC. | c13127exv21.htm |
EX-11 - EXHIBIT 11 - NOVELION THERAPEUTICS INC. | c13127exv11.htm |
EX-23 - EXHIBIT 23 - NOVELION THERAPEUTICS INC. | c13127exv23.htm |
EX-32.1 - EXHIBIT 32.1 - NOVELION THERAPEUTICS INC. | c13127exv32w1.htm |
EX-31.1 - EXHIBIT 31.1 - NOVELION THERAPEUTICS INC. | c13127exv31w1.htm |
EX-31.2 - EXHIBIT 31.2 - NOVELION THERAPEUTICS INC. | c13127exv31w2.htm |
EX-10.54 - EXHIBIT 10.54 - NOVELION THERAPEUTICS INC. | c13127exv10w54.htm |
10-K - FORM 10-K - NOVELION THERAPEUTICS INC. | c13127e10vk.htm |
EXHIBIT 32.2
CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of QLT Inc. (the Company), on Form 10-K for the fiscal year
ended December 31, 2010, as filed with the Securities and Exchange Commission (the Report), I,
Cameron R. Nelson, Vice President, Finance & Chief Financial Officer of the Company, hereby certify
as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934; and |
||
(2) | The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company at the dates
and for the periods indicated. |
Dated: March 1, 2011
/s/ Cameron R. Nelson | ||||
Cameron R. Nelson | ||||
Vice President, Finance & Chief Financial Officer (Principal Financial and Accounting Officer) QLT Inc. |
||||